MTOR and cancer: In breast cancer, Cheng et al. [16] first proposed MNX1-AS1 acted as a functional oncogene that could induce the epithelial-mesenchymal transition of cancer cells via activation of AKT/mTOR signaling pathway and upregulation of its natural sense transcript MNX1.